Bariatric Surgery for the Treatment of Morbid Obesity: Early effects on Glycemic Control, Inflammatory and Carotid Arteries Wall Thickness Status
Journal Title: Journal of Obesity and Bariatrics - Year 2015, Vol 2, Issue 1
Abstract
Background: Cardiovascular diseases and type 2 diabetes mellitus (T2DM) are the leading reasons for premature morbidity and mortality in patients with extreme obesity. Currently, there is limited success in changing this course by nutritional and pharmacological intervention. Therefore, we have attempted to assess the early effects of bariatric surgery on metabolic, glycemic, inflammatory and on carotid arteries wall thickness status in obese patients, all of them mediate accelerated atherosclerotic in these patients. Methods: Twenty two patients, 11 with and 11 without T2DM were followed for three months after surgery. Fasting blood glucose, HbA1C and lipids were performed and carotid intima-media thickness (IMT) was measured. Results: Bariatric surgery resulted in a significant weight loss from 126±24 to 102±21 kg (mean±SD, p<0.0001) with a 46±13% reduction in excess weight (EWL). Some markers of inflammation dropped significantly: White blood cells (WBC) from 9.3x103 to 7.6x103/μL and C-Reactive Protein (CRP) from 13.5 to 8.2 mg/L (p<0.0001). Fasting glucose decreased from 126 to 102 mg/dL (p=0.006) while HbA1C decreased from 7.2% to 5.7% (p<0.0001). In patients with diabetes, fasting glucose dropped from 162 to 122 mg/dL(p=0.04) whereas HbA1C dropped from 8.2 to 5.9% (p=0.005), thus moving from a diabetic to a non-diabetic range. IMT did not show any improvement throughout the 3 month study. Conclusion: Bariatric surgery had dramatic effects on glycemic control and inflammatory status in patients with T2DM as early as three months after surgery. If sustained, such response after surgery may confer protection against future cardiovascular morbidity and mortality through mechanisms presented in our study.
Authors and Affiliations
Yishai Levy
Keywords
Related Articles
- EP ID EP205454
- DOI 10.13188/2377-9284.1000010
- Views 128
- Downloads 0
Post-Surgical Effects of Roux-En-Y Gastric Bypass on Glucose Homeostasis, Intestinal Morphology and L-Cells in Obese Gottingen Minipigs
Background: Roux-en-Y gastric bypass (RYGB) is currently the most effective treatment of morbid obesity in man. In rodents, RYGB leads to a number of morphological changes in the intestine. However, little is known about...
Revisional Bariatric Surgery
Background: To elucidate percent excess body weight loss (%EBWL) gained from revisional surgery and to determine resolution of comorbid conditions given the obesity epidemic.Methods: All patients undergoing revisional ba...
Portomesentric Vein Thrombosis: Our Experience of 3527 Laparoscopic Bariatric Surgery Procedures in Qatar
Background: Portomesentric vein thrombosis (PMVT) is a rare but potentially serious and life threatening complication that may happen following laparoscopic bariatric surgery (LBS). Multifactorial local and systemic prot...
Pediatric Gastric Bypass: Is it Time to Rethink? Lessons Learned from a Single Institution Experience
Pediatric obesity is a growing problem in United States. Ideally, a non-operative option is preferred but currently there is no medical treatment that guarantees an enduring weight loss. Laparoscopic adjustable gastric b...
The Exaggeration of Food Addiction: Most Weight-Controllers are Athletes, not Addicts
Food addiction has become a popular notion in the media and the scientific community, with many proposing that an addiction to food causes obesity. Although food addictions may affect some people, this notion may also pr...